Nestle logo

Nestle

NESTLEIND NSE

Key Fundamentals

LargecapPackaged FoodsFood Products
Market Cap
2.7L Cr
Volatility
Moderate
P/E Ratio
69.06
EBITDA
₹5,346 Cr
Return on Equity
67.85%
Debt to Equity
0.08
Book Value
₹26.74
EPS
₹33.58
52W High
₹1,553
52W Low
₹1,145

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 92.3%
  • Company has been maintaining a healthy dividend payout of 74.3%

Weaknesses

2
  • Stock is trading at 50.2 times its book value
  • The company has delivered a poor sales growth of 11.6% over past five years.

Growth Rate

Revenue Growth
14.48% higher than 3Y
Net Income Growth
9.09% lower than 3Y
Cash Flow Change
71.9% higher than 3Y
ROE
-15.18% lower than 3Y
ROCE
-5.43% higher than 3Y
EBITDA Margin (Avg.)
-3.35% higher than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 2d ago
AI opinion · based on fundamentals
Risk medium

Nestle India Ltd commands a market cap of ₹2,67,515 Cr with a PE of 70.7x and a price-to-book of 52.2x, reflecting significant premium valuation. The company is virtually debt-free with a 3-year ROE of 92% and TTM sales growth of 19%, though its 5-year sales CAGR of ~12% has been modest relative to its valuation multiple.

Bull Case 8
  • Virtually debt-free balance sheet, providing strong financial flexibility and resilience during economic downturns
  • Exceptional return on equity with a 3-year average ROE of 92% and 5-year average of 98%, indicating highly efficient capital deployment
  • TTM revenue growth accelerated to 19%, well above the 5-year compounded sales CAGR of 12%, signaling improving demand momentum
  • TTM profit growth of 25% outpaces TTM sales growth of 19%, reflecting margin expansion and operating leverage
  • Consistent dividend payout ratio of 74.3% with a current yield of 1.01%, offering reliable income in a low-debt structure
  • 10-year compounded profit CAGR of 15% demonstrates long-term earnings compounding ability across market cycles
  • 10-year stock price CAGR of 16% shows sustained long-term wealth creation for shareholders
  • Company has actively reduced debt, further strengthening an already clean balance sheet
Bear Case 8
  • PE ratio of 70.7x is significantly elevated compared to broader market and FMCG sector averages, leaving limited margin of safety
  • Price-to-book of 52.2x implies the stock trades at an extreme premium to its net asset value
  • 5-year compounded sales growth of only 12% is modest for a stock commanding a 70x earnings multiple
  • Last year ROE declined to 73% from a 5-year average of 98%, suggesting potential deterioration in capital efficiency
  • 1-year stock CAGR of 14% and 3-year CAGR of 8% show decelerating price returns, lagging the 10-year CAGR of 16%
  • Dividend yield of just 1.01% offers limited income compensation for the premium valuation paid
  • 5-year stock CAGR of only 6% indicates prolonged periods of muted returns despite earnings growth, suggesting valuation compression risk
  • 3-year sales CAGR of 11% is in line with the 10-year average, indicating limited acceleration in the underlying business growth rate

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Headwinds 4
  • HFSS labelling regulatory risk Aug 27

    FSSAI pushing front-of-pack warning labels for high fat/sugar/salt foods. Industry estimates ~80% of India's $100B+ packaged food market could be classified HFSS, threatening widespread red warnings across Nestle's portfolio.

  • Five-session stock decline Sep 7

    Stock fell to ₹1,398.8, down 0.83% on the day and 8.49% over the past month, underperforming the Nifty FMCG index's 7.62% decline. PE ratio remains elevated at 72.93x trailing earnings.

  • Customs duty penalties Aug 26

    Two customs orders demand ₹11.1 crore and ₹2.47 crore in duty plus penalties. Company states no material financial impact and plans to challenge both orders.

  • Sugar double-standards scrutiny Aug 27

    Indian Cerelac contains 2.7g added sugar per serving vs zero in the UK; Indian KitKats have 4.5% cocoa solids vs 22% in Australia. Consumer backlash and Supreme Court intervention amplify reputational risk.

Positives 4
  • Strong Q1 FY27 earnings Aug 27

    Q1 FY27 revenue rose 25.75% to ₹6,385.74 crore with net profit up 48.27% to ₹958.68 crore. Project Shark efficiency program generates ₹1.5-2 billion in annual savings.

  • Solar stake for renewables Aug 27

    Acquired 26% equity stake in Radiance KA Sunshine Seven Pvt Ltd for ₹7.61 crore to support captive renewable energy goals.

  • Solid long-term outperformance Sep 7

    Stock up 17.77% over the past year, significantly outperforming Nifty's 4.11% decline and Nifty FMCG's 18.81% fall over the same period.

  • Proactive health reformulation Aug 27

    Reduced added sugars by up to 30% in infant cereals over five years and launched Zero Added Sucrose Cerelac variants. Products launched since 2015 now contribute over 5% of sales.

Neutral 2
  • GST penalty reduced on appeal Sep 9

    GST order-in-appeal reduced penalty to ₹12.97 lakh with tax liability of ₹1.30 crore for FY17-20. Company plans to challenge the order further.

  • Investor meet concluded Aug 31

    One-on-one meeting with an institutional investor held Aug 31 in Mumbai. Company confirmed no unpublished price-sensitive information was shared under SEBI Regulation 30.

TL;DR: Nestle India delivered strong Q1 FY27 results with 25.75% revenue growth and 48.27% profit growth, and the stock has outperformed both Nifty and Nifty FMCG over the past year. However, near-term sentiment is weak with five consecutive sessions of decline and an 8.49% monthly drop. The biggest structural risk is FSSAI's push for HFSS warning labels, which could affect a large portion of the product portfolio, though Nestle's global R&D scale and ongoing reformulation efforts position it better than most peers. The trend is deteriorating short-term on regulatory overhang and selling pressure, but fundamentals remain solid if the company continues adapting proactively.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
4,659
5,037
4,600
5,268
4,814
5,104
4,780
5,504
5,096
5,644
5,667
6,748
6,378
Expenses
3,603
3,812
3,505
3,918
3,700
3,936
3,677
4,116
3,996
4,407
4,466
4,976
4,840
Operating Profit
1,056
1,225
1,095
1,350
1,114
1,168
1,103
1,388
1,100
1,237
1,201
1,772
1,538
OPM %
23%
24%
24%
26%
23%
23%
23%
25%
22%
22%
21%
26%
24%
Other Income
24
140
-77
37
39
298
4
9
4
2
170
-18
16
Interest
33
31
23
26
32
32
35
38
47
46
28
37
42
Depreciation
107
111
109
110
113
122
150
155
157
163
174
205
188
PBT
939
1,222
886
1,251
1,009
1,312
922
1,205
900
1,029
1,168
1,513
1,324
Tax %
26%
26%
26%
25%
26%
25%
25%
26%
27%
27%
13%
26%
26%
Net Profit
698
908
656
934
747
986
696
885
659
753
1,018
1,114
975
EPS in Rs
3.62
4.71
3.4
4.84
3.87
5.12
3.61
4.59
3.42
3.91
5.28
5.78
5.06
Figures in ₹ Crores

Profit & Loss

Particulars Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Mar 2024 15mMar 2025Mar 2026TTM
Sales
8,175
9,141
10,010
11,292
12,369
13,350
14,741
16,897
19,126
24,394
20,202
23,155
24,437
Expenses
6,620
7,292
7,913
8,675
9,443
10,149
11,178
13,191
14,655
18,551
15,430
17,848
18,689
Operating Profit
1,555
1,850
2,097
2,618
2,926
3,202
3,562
3,706
4,471
5,843
4,771
5,307
5,747
OPM %
19%
20%
21%
23%
24%
24%
24%
22%
23%
24%
24%
23%
24%
Other Income
-391
140
177
259
247
146
-112
107
116
159
352
160
170
Interest
3
91
92
112
129
164
202
155
119
145
136
158
154
Depreciation
347
354
342
336
370
370
391
403
429
568
540
699
730
PBT
814
1,545
1,839
2,429
2,673
2,813
2,857
3,256
4,038
5,289
4,447
4,610
5,034
Tax %
31%
35%
33%
34%
26%
26%
26%
27%
26%
26%
25%
23%
Net Profit
563
1,001
1,225
1,607
1,968
2,082
2,118
2,391
2,999
3,933
3,314
3,545
3,860
EPS in Rs
2.92
5.19
6.35
8.33
10.21
10.8
10.99
12.4
15.55
20.4
17.19
18.38
20.03
Div. Payout %
83%
61%
68%
69%
168%
93%
91%
89%
56%
79%
79%
65%
Figures in ₹ Crores

Balance Sheet

Particulars Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Mar 2024Mar 2025Mar 2026
Equity Capital
96
96
96
96
96
96
96
96
96
96
96
193
Reserves
2,721
3,186
3,324
3,577
1,822
1,923
1,850
2,363
2,363
3,244
4,021
5,116
Borrowings
18
33
35
35
189
147
266
271
271
345
1,167
444
Other Liabilities
3,251
3,495
3,907
4,379
5,065
5,733
6,021
6,249
6,249
6,838
7,040
7,604
Total Liabilities
6,086
6,810
7,363
8,088
7,173
7,900
8,234
8,979
8,979
10,523
12,324
13,357
Fixed Assets
2,898
2,730
2,616
2,401
2,341
2,179
2,995
3,044
3,044
3,460
5,474
6,290
CWIP
231
188
94
105
143
639
246
358
358
1,742
1,173
507
Investments
1,325
1,756
1,979
2,658
1,751
1,464
774
778
778
464
706
706
Other Assets
1,633
2,136
2,673
2,924
2,937
3,618
4,219
4,799
4,799
4,857
4,972
5,854
Total Assets
6,086
6,810
7,363
8,088
7,173
7,900
8,234
8,979
8,979
10,523
12,324
13,357
Figures in ₹ Crores

Cash Flow

Particulars Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Mar 2024Mar 2025Mar 2026
Operating
1,098
1,466
1,818
2,052
2,295
2,454
2,236
2,737
3,392
4,175
2,935
5,048
Investing
-70
-126
-131
-52
83
-321
-1,920
-392
-927
-1,237
-1,811
-624
Financing
-498
-666
-997
-1,317
-3,602
-1,956
-2,020
-2,123
-2,436
-3,135
-1,846
-3,179
Net Cash Flow
529
674
691
683
-1,223
177
-1,704
223
29
-198
-723
1,244
Free Cash Flow
949
1,353
1,622
1,890
2,143
1,980
1,505
2,197
2,028
2,296
930
4,221
CFO/OP
93
106
116
112
101
99
83
97
100
94
82
115
Figures in ₹ Crores

Ratios

Particulars Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Mar 2024Mar 2025Mar 2026
Debtor Days
4
4
3
4
4
5
4
4
4
4
7
5
Inventory Days
103
107
91
92
107
107
111
110
83
83
139
105
Days Payable
94
91
99
118
124
115
122
121
92
112
128
129
Cash Conversion Cycle
12
20
-5
-22
-14
-3
-7
-7
-5
-24
18
-19
Working Capital Days
-21
-10
-15
-21
-20
-22
-20
-16
-10
-19
-19
-24
ROCE %
46%
54%
57%
71%
96%
139%
150%
138%
153%
169%
96%
84%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Nestle insights

73 extracted metrics + investor summaries across FY01–FY27.

Log in — free

Shareholding Pattern

Others3.06%Promot.62.76%FIIs10.29%DIIs11.90%Public11.98%As ofJun 2026

Documents

Frequently Asked Questions about Nestle

What does Nestle India Ltd do?
Nestle India Limited is a subsidiary of Nestle which is a Swiss MNC. The company operates in the Food segment.
Where is Nestle India Ltd (NESTLEIND) listed?
Nestle India Ltd trades as NESTLEIND on the NSE and under code 500790 on the BSE.
Which sector does Nestle India Ltd belong to?
Nestle India Ltd is classified under the Food Products sector, in the Packaged Foods industry.
What is the market capitalisation of Nestle India Ltd?
Nestle India Ltd has a market capitalisation of ₹2,67,515 Cr, which places it in the Large Cap band.
What is the PE ratio of Nestle India Ltd?
Nestle India Ltd trades at a PE ratio of 69.06, on earnings per share of ₹33.58, against a book value of ₹26.74 per share.
What is the 52-week high and low of Nestle India Ltd?
Over the last 52 weeks Nestle India Ltd has traded between ₹1,145 and ₹1,553.
Does Nestle India Ltd pay dividends?
Nestle India Ltd has a dividend yield of 1.01%.
What is the Return on Equity (ROE) of Nestle India Ltd?
Nestle India Ltd reported a return on equity of 67.85%. Its debt-to-equity ratio is 0.08.

Company Information

Nestle India Limited is a subsidiary of Nestle which is a Swiss MNC. The company operates in the Food segment.

Website nestle.in
Employees 8,419
Listed 1998-12-03
Face Value ₹ 1
Issued Size 1,92,83,14,320

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NESTLEIND.md for Nestle India Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More